Over a decade into selling Korlym to treat endogenous hypercortisolism, also known as Cushing syndrome, Corcept Therapeutics ...

The U.S. Food and Drug Administration has approved Neurocrine Biosciences' drug to treat a type of genetic disorder, the ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) said that the primary endpoint was met in the treatment phase of CATALYST, a ...

Avoiding the hunger trap and the binge-eating cravings is difficult. Overeating or eating unhealthy foods can often derail ...

Researchers investigate the effectiveness of placental nano-based insulin-like 1 growth factor gene therapy to correct fetal ...

Bone material strength index values were found to be low in patients with Cushing syndrome even after long-term remission, indicating persistent impairment of tissue-level bone properties.

New research shows that glioblastoma has an internal clock and syncs its daily rhythms to match -- and take advantage of -- the rhythms of its host. In this way, brain tumors grow in response to the ...

Blue-light emergency responders are in real danger of burnout with recovery periods between incidents essential for their long-term health according to the results of a first-of-its-kind study.

Research from Washington University shows that glioblastoma, a type of brain cancer, has its own internal clock that ...

Virtually every cell in the human body has an internal clock. These clocks take their cues from a central clock in the brain. In a normal, biological process called synchrony, the central clock ...

Through a negative feedback mechanism, an increase in circulating cortisol results in the inhibition ... therapy continues beyond 14-21 days to control symptoms of brain tumors, and gradual ...